JP2010523662A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523662A5
JP2010523662A5 JP2010503031A JP2010503031A JP2010523662A5 JP 2010523662 A5 JP2010523662 A5 JP 2010523662A5 JP 2010503031 A JP2010503031 A JP 2010503031A JP 2010503031 A JP2010503031 A JP 2010503031A JP 2010523662 A5 JP2010523662 A5 JP 2010523662A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
desmethylvenlafaxine
composition according
administered
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010503031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523662A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004508 external-priority patent/WO2008124128A2/en
Publication of JP2010523662A publication Critical patent/JP2010523662A/ja
Publication of JP2010523662A5 publication Critical patent/JP2010523662A5/ja
Pending legal-status Critical Current

Links

JP2010503031A 2007-04-09 2008-04-08 睡眠関連呼吸障害を処置するための方法及び組成物 Pending JP2010523662A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
PCT/US2008/004508 WO2008124128A2 (en) 2007-04-09 2008-04-08 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders

Publications (2)

Publication Number Publication Date
JP2010523662A JP2010523662A (ja) 2010-07-15
JP2010523662A5 true JP2010523662A5 (https=) 2011-05-19

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503031A Pending JP2010523662A (ja) 2007-04-09 2008-04-08 睡眠関連呼吸障害を処置するための方法及び組成物

Country Status (15)

Country Link
US (3) US20080293823A1 (https=)
EP (2) EP2455076A1 (https=)
JP (1) JP2010523662A (https=)
KR (1) KR20100015923A (https=)
CN (1) CN101686955A (https=)
AR (1) AR065989A1 (https=)
AU (1) AU2008236624A1 (https=)
BR (1) BRPI0810159A2 (https=)
CA (1) CA2683697C (https=)
IL (1) IL201430A0 (https=)
MX (1) MX2009010805A (https=)
NZ (1) NZ580250A (https=)
RU (1) RU2009141168A (https=)
TW (1) TW200901956A (https=)
WO (1) WO2008124128A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012007813A (es) * 2010-01-07 2012-08-01 Vivus Inc Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
EP3746126B1 (en) 2018-01-30 2024-07-31 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea or simple snoring
EP4635514A3 (en) * 2019-02-08 2025-12-24 The Brigham & Women's Hospital, Inc. Methods and compositions for treating sleep apnea

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US6110973A (en) 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
DE60039132D1 (de) * 1999-04-06 2008-07-17 Sepracor Inc O-Desmethylvenlafaxin-Succinat
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
NZ548856A (en) * 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039867A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders with setiptiline
KR20070087678A (ko) * 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
AU2006255047B2 (en) * 2005-06-06 2011-09-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating sleep disorders
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
KR101528326B1 (ko) * 2007-02-21 2015-06-11 선오비온 파마슈티컬스 인코포레이티드 (―)o―데스메틸벤라팍신을 포함하는 고체 형태들 및 그들의 용도
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

Similar Documents

Publication Publication Date Title
JP2025120201A (ja) 患者インターフェース
Gavel et al. Laryngospasm in anaesthesia
US10271985B2 (en) Valved nasal cannula
JP5230202B2 (ja) 呼吸デバイス及びそのキット
JP5513519B2 (ja) エアロゾル医薬輸送のための方法及びステップ構造を有するマウスピースを含む装置
CN103405843B (zh) 一种随体位变化调节呼气正压的通气面罩
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2010523662A5 (https=)
DK1715859T3 (da) Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden
RU2009141168A (ru) Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна
Fahim et al. Chronic opioid use: a risk factor for central sleep apnoea and successful therapy with adaptive pressure support servo-ventilation
Choi et al. Treatment of obstructive sleep apnea with positive pressure ventilation
WO2014028993A1 (pt) Sistema dissuasivo do ronco e congéneres
TWI872958B (zh) 止鼾器
CN203425348U (zh) 一种随体位变化调节呼气正压的通气面罩
Verse et al. Sleep Disorders and the Nose: What Is the Evidence Base?
Chakupurakal et al. 1151 Lateral Head Position Improves Supine Predominant Obstructive Sleep Apnea
Spencer et al. 1152 The Case of the Auto-PAP that did not Work
Lenhardt et al. Continuous positive airway pressure
Lyons Pediatric respiratory complication after general anesthesia with exposure to environmental tobacco smoke in the home: a case report.
JP2012016600A (ja) うつぶせ寝用枕
Patel et al. Nasal High-Flow Oxygen Therapy for Sleep-Related Hypoventilation in Acute on Chronic Respiratory Failure
Fahim Sleep study and polysomnography data
Amaro et al. The Use Of Nasal Dilators As Placebo For Trials Using Continuous Positive Airway Pressure
Porhomayon et al. Case Report Application of Dual Mask for Postoperative Respiratory Support in Obstructive Sleep Apnea Patient